HomeLab TestsCA 19-9 Blood Test (Pancreatic Cancer)
Back to Lab Tests
CA 19-9 Blood Test (Pancreatic Cancer)
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Lab Tests

CA 19-9 Blood Test (Pancreatic Cancer)

The CA 19-9 blood test measures a tumor marker protein to help monitor digestive tract cancers and evaluate treatment effectiveness.

What is a CA 19-9 blood test?

A CA 19-9 test measures the amount of a protein called CA 19-9 (cancer antigen 19-9) in your blood. It is a type of tumor marker made by cancer cells or normal cells in response to cancer.

High levels can be a sign of cancers of the pancreas, bile duct, colon, rectum, stomach, ovaries, or bladder. However, high levels can also result from non-cancerous conditions, including gallstones, pancreatitis, cirrhosis, liver disease, or cystic fibrosis.

What is it used for?

CA 19-9 blood tests may be used to:

  • Monitor cancer and cancer treatment: Levels often rise as cancer grows and fall as tumors shrink.
  • Make a prognosis: Helps determine the cancer's stage and likelihood of responding to treatment.
  • Check for recurrence: Used to see if cancer has returned after treatment.
  • Check for the presence of cancer: Used only in conjunction with other tests, such as physical exams, imaging (CT/MRI), or cholangiopancreatography.

Why do I need a CA 19-9 test?

You may need this test if you have been diagnosed with a cancer associated with CA 19-9, are undergoing or have completed cancer treatment, or are experiencing symptoms such as jaundice, weight loss, abdominal pain, weakness, or a swollen gallbladder or liver.

What happens during a CA 19-9 blood test?

A health care professional will take a blood sample from a vein in your arm. The process usually takes less than five minutes.

Will I need to do anything to prepare for the test?

Usually, no special preparation is required, but you should ask your provider, as you may need to stop taking certain vitamins before the test.

Are there any risks to the test?

There is very little risk, such as slight pain or bruising at the needle site, which typically goes away quickly.

What do the results mean?

If you are being treated for cancer, your provider will look at how your levels change over time:

  • Increasing levels: May mean the tumor is growing or treatment is not working.
  • Decreasing levels: May mean the tumor is shrinking and treatment is working.
  • Stable levels: May mean the disease is stable.
  • Levels decreased then increased: May mean the cancer has returned.

If you do not have cancer, high levels may indicate a condition like pancreatitis or gallstones, and further testing will be required.

Is there anything else I need to know about a CA 19-9 test?

Because different labs use different methods to measure CA 19-9, it is important to have your tests performed at the same lab over time to ensure your provider can accurately compare your results.

Frequently Asked Questions

CA 19-9 is not specific to cancer; it can be elevated in benign conditions such as gallstones, pancreatitis, liver cirrhosis, or cholestasis (bile flow obstruction). Because of this, a single elevated result is not diagnostic for cancer and must be interpreted alongside imaging tests like CT or MRI and other blood work to rule out non-malignant causes.
CA 19-9 levels typically decline within a few weeks if the treatment is effective, but the rate of decline varies by individual and cancer type. A steady decrease is a positive sign, while a plateau or rise may indicate that the cancer is not responding to the current therapy. Your oncologist will schedule follow-up blood tests at regular intervals to track these trends.
No, a low or normal CA 19-9 level does not guarantee the absence of cancer. Some patients with pancreatic cancer never produce significant amounts of CA 19-9, or the tumor may be too small to affect blood levels. Conversely, a normal level after treatment is a good sign but must be confirmed with imaging studies to ensure no residual disease remains.
No, the CA 19-9 test is not recommended for routine screening in the general population or even in high-risk groups without other specific indicators. It has a high rate of false positives and false negatives. It is primarily used to monitor known cancer cases, track treatment response, or detect recurrence after treatment.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss